Clinical Trial

A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men

Name: A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men — clinical trial record (NCT07314320)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the relative amounts of radioactivity excreted in urine and feces following a single oral dose of \[14C\]-OPC-167832 in healthy male participants.

Trial Details

NCT Number	NCT07314320
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	Healthy Volunteers
Enrollment	8 participants
Start Date	2023-11-20
Primary Completion	2023-12-27 (estimated)
Study Completion	2023-12-27 (estimated)
Updated on ClinicalTrials.gov	2026-01-02